Ernexa Therapeutics Inc. SEC filings ERNAW
Ernexa Therapeutics Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jun 3, 2010. Its latest annual report, Form ARS, was filed on May 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | May 11, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 13, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 14, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 12, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Oct 16, 2024 | Dec 31, 2023 |
| 10-K/A | Amended annual report | Mar 18, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 14, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | May 5, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 20, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | Jul 1, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Apr 15, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 11, 2021 | Dec 31, 2020 |
| 10-K/A | Amended annual report | Apr 27, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 19, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 22, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 9, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 9, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 15, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Mar 27, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 31, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Mar 29, 2013 | Dec 31, 2012 |
| 10-K | Annual report | Mar 30, 2012 | Dec 31, 2011 |
| 10-K | Annual report | Mar 25, 2011 | Dec 31, 2010 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ERNA (Nasdaq), ERNAW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 748592
- Former names
- Eterna Therapeutics Inc. (until Apr 4, 2025); Brooklyn ImmunoTherapeutics, Inc. (until Oct 14, 2022); NTN BUZZTIME INC (until Mar 23, 2021); NTN COMMUNICATIONS INC (until Dec 20, 2005)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.